BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7587576)

  • 1. [Amplification of proto-oncogenes C-myc, C-N-ras, C-Ki-ras, C-erbB2 in ovarian carcinoma].
    Bian M; Fan Q; Huang S
    Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):406-9. PubMed ID: 7587576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplifications of proto-oncogenes in ovarian carcinoma.
    Bian M; Fan Q; Huang S; Ma J; Lang J
    Chin Med J (Engl); 1995 Nov; 108(11):844-8. PubMed ID: 8585978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogene patterns in breast and ovarian carcinomas.
    Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
    Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amplification of C-erB2 gene in ovarian cancer].
    Zhang GL; Zu KL; Yu SY
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):401-3, 444. PubMed ID: 8001415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay.
    Fukumoto M; Estensen RD; Sha L; Oakley GJ; Twiggs LB; Adcock LL; Carson LF; Roninson IB
    Cancer Res; 1989 Apr; 49(7):1693-7. PubMed ID: 2647292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [c-erbB2 gene amplification in human primary epithelial ovarian cancer and its clinical significance].
    Yang H; Zhang G; Xu K
    Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):367-70. PubMed ID: 10921034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative detection of amplification of proto-oncogenes in breast cancer.
    Chen Y; Dong J; Lu Y; McGee JO
    Chin Med J (Engl); 1995 Nov; 108(11):849-54. PubMed ID: 8585979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of proto-oncogene amplification in human malignant diseases.
    Masuda H; Battifora H; Yokota J; Meltzer S; Cline MJ
    Mol Biol Med; 1987 Aug; 4(4):213-27. PubMed ID: 3670047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
    Shiraishi M; Noguchi M; Shimosato Y; Sekiya T
    Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer.
    Yao M; Shuin T; Misaki H; Kubota Y
    Cancer Res; 1988 Dec; 48(23):6753-7. PubMed ID: 2460228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene amplification detected by in situ hybridization in radiation-induced skin cancers in rats.
    Jin Y; Burns FJ; Garte SJ
    Radiat Res; 1992 Nov; 132(2):193-9. PubMed ID: 1438701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relation between prognosis and amplification of the c-erB-2 (HER-2/neu) proto-oncogene in ovarian carcinomas].
    Fan QB; Bian ML; Huang SZ
    Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):683-5, 710. PubMed ID: 7866905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between hypomethylation of c-myc and c-N-ras oncogenes and pathological changes in human hepatocellular carcinoma].
    Shen L; Qui D; Fang J
    Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):173-6. PubMed ID: 10920889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of amplifications of myc gene (c-myc and N-myc) in human ovarian cancer].
    Kataoka A; Yakushiji M; Kojiro M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Mar; 42(3):259-63. PubMed ID: 2332674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
    Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alterations of c-myc and c-Ha-ras-1 oncogenes in human ovarian cancer].
    Serova OM; Nikiforova IF; Iurkova LE; Vinokurov VL; Kniazev PG
    Eksp Onkol; 1990; 12(6):47-9. PubMed ID: 2261877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression and amplification of c-myc and c-Ha-ras oncogenes in pleomorphic salivary adenoma.
    Xue H; Situ ZQ; Wang CJ; Wu JZ
    Chin Med J (Engl); 1993 Jan; 106(1):22-5. PubMed ID: 8389270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ras oncogene activation in human ovarian carcinoma.
    van 't Veer LJ; Hermens R; van den Berg-Bakker LA; Cheng NC; Fleuren GJ; Bos JL; Cleton FJ; Schrier PI
    Oncogene; 1988 Feb; 2(2):157-65. PubMed ID: 3285294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.